Equillium Reports Third Quarter 2018 Financial Results and Recent Highlights
November 15, 2018 16:07 ET
|
Equillium, Inc.
Completes Successful Initial Public Offering Raising Gross Proceeds of Approximately $71.6 Million On-Track for Early 2019 Initiation of Phase 1b/2 Trial of EQ001 in Acute Graft-Versus-Host Disease ...